NCT03121638View on ClinicalTrials.gov

Safety Study of NBP608 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Varicella ZosterImmunization; Infection
Interventions
BIOLOGICAL

VARIVAX

Preparation of Oka/Merck strain of live, attenuated varicella zoster virus

BIOLOGICAL

ZOSTAVAX

Preparation of Oka/Merck strain of live, attenuated varicella zoster virus

BIOLOGICAL

NBP6081

Preparation of Oka/SK strain of live, attenuated varicella zoster virus

BIOLOGICAL

NBP6082

Preparation of Oka/SK strain of live, attenuated varicella zoster virus

BIOLOGICAL

NBP6083

Preparation of Oka/SK strain of live, attenuated varicella zoster virus

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT03121638 - Safety Study of NBP608 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter